Spain is investigating Novo Nordisk for potentially illegal advertising of its weight loss drugs, Ozempic and Wegovy. This follows similar inquiries in other European countries. Health officials are concerned that the company is violating EU laws by promoting these medications under the guise of raising awareness about obesity. A recent campaign titled 'Obesidad Sin Filtros' aimed to inform the public about obesity risks but is seen as covert advertising for the drugs. The Spanish health ministry is seeking more information from Novo Nordisk and may impose fines if violations are found. Teljes cikk (Euronews.com)